New study tests best first treatment for severe blood disorder
NCT ID NCT07338422
First seen Jan 19, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This study compares two first-line treatments for severe aplastic anemia, a condition where the bone marrow fails to produce enough blood cells. It will involve 116 patients aged 14-70 who lack a fully matched donor. One group receives a stem cell transplant from a half-matched family donor, while the other gets strong immune-suppressing drugs. The goal is to see which approach leads to better survival and recovery without treatment failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.